The performance of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the loss of exclusivity in key regions has introduced considerable uncertainty . Investors are now assessing the consequences of lower-